La Jolla Pharmaceutical Company
NASDAQ:
LJPC
-
USD
BIOTECHNOLOGY
$3.76
-$0.11
(-2.87%)
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy La Jolla Pharmaceutical Company (LJPC) stock
Learn how to easily invest in La Jolla Pharmaceutical Company stock.
La Jolla Pharmaceutical Company is a biotechnology business based in the US. La Jolla Pharmaceutical Company shares (LJPC) are listed on the NASDAQ and all prices are listed in US Dollars. La Jolla Pharmaceutical Company employs 59 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in La Jolla Pharmaceutical Company
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – LJPC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Building a portfolio
Our top pick for
Social investors
Our top pick for
Beginners
What's in this guide?
- LJPC shares summary
- Compare share dealing platforms
- Is LJPC stock a buy or sell?
- Stock performance over time
- Can I short LJPC shares?
- La Jolla Pharmaceutical Company's financials
- How volatile are LJPC shares?
- Does La Jolla Pharmaceutical Company pay a dividend?
- Have LJPC shares ever split?
- Other common questions
La Jolla Pharmaceutical Company stock price (NASDAQ: LJPC)
Use our graph to track the performance of LJPC stocks over time.La Jolla Pharmaceutical Company shares at a glance
Information last updated 2021-07-23.
| Latest market close | $4.30 |
|---|---|
| 52-week range | $3.35 - $7.85 |
| 50-day moving average | $4.44 |
| 200-day moving average | $4.79 |
| Wall St. target price | $9.75 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-5.92 |
Buy La Jolla Pharmaceutical Company shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy La Jolla Pharmaceutical Company stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
La Jolla Pharmaceutical Company price performance over time
Historical closes compared with the close of $4.3 from 2021-05-28
| 1 week (2021-07-12) | 8.31% |
|---|---|
| 1 month (2021-06-23) | -5.08% |
| 3 months (2021-04-19) | N/A |
| 6 months (2021-01-19) | N/A |
| 1 year (2020-07-19) | N/A |
|---|---|
| 2 years (2019-07-19) | N/A |
| 3 years (2018-07-19) | N/A |
| 5 years (2016-07-19) | N/A |
Is La Jolla Pharmaceutical Company under- or over-valued?
Valuing La Jolla Pharmaceutical Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of La Jolla Pharmaceutical Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
La Jolla Pharmaceutical Company's EBITDA
La Jolla Pharmaceutical Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5.1 million.
The EBITDA is a measure of a La Jolla Pharmaceutical Company's overall financial performance and is widely used to measure a its profitability.
La Jolla Pharmaceutical Company financials
| Revenue TTM | $60 million |
|---|---|
| Operating margin TTM | 4.91% |
| Gross profit TTM | $28.1 million |
| Return on assets TTM | 1.77% |
| Return on equity TTM | 0% |
| Profit margin | -27.37% |
| Book value | $-0.61 |
| Market capitalisation | $106.3 million |
TTM: trailing 12 months
Shorting La Jolla Pharmaceutical Company shares
There are currently 1.8 million La Jolla Pharmaceutical Company shares held short by investors – that's known as La Jolla Pharmaceutical Company's "short interest". This figure is 23% down from 2.3 million last month.
There are a few different ways that this level of interest in shorting La Jolla Pharmaceutical Company shares can be evaluated.
La Jolla Pharmaceutical Company's "short interest ratio" (SIR)
La Jolla Pharmaceutical Company's "short interest ratio" (SIR) is the quantity of La Jolla Pharmaceutical Company shares currently shorted divided by the average quantity of La Jolla Pharmaceutical Company shares traded daily (recently around 384450.74626866). La Jolla Pharmaceutical Company's SIR currently stands at 4.69. In other words for every 100,000 La Jolla Pharmaceutical Company shares traded daily on the market, roughly 4690 shares are currently held short.
However La Jolla Pharmaceutical Company's short interest can also be evaluated against the total number of La Jolla Pharmaceutical Company shares, or, against the total number of tradable La Jolla Pharmaceutical Company shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case La Jolla Pharmaceutical Company's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 La Jolla Pharmaceutical Company shares in existence, roughly 70 shares are currently held short) or 0.1323% of the tradable shares (for every 100,000 tradable La Jolla Pharmaceutical Company shares, roughly 132 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against La Jolla Pharmaceutical Company.
Find out more about how you can short La Jolla Pharmaceutical Company stock.
La Jolla Pharmaceutical Company share dividends
We're not expecting La Jolla Pharmaceutical Company to pay a dividend over the next 12 months.
Have La Jolla Pharmaceutical Company's shares ever split?
La Jolla Pharmaceutical Company's shares were split on a 1:50 basis on 13 January 2014. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your La Jolla Pharmaceutical Company shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for La Jolla Pharmaceutical Company shares which in turn could have impacted La Jolla Pharmaceutical Company's share price.
La Jolla Pharmaceutical Company share price volatility
Over the last 12 months, La Jolla Pharmaceutical Company's shares have ranged in value from as little as $3.35 up to $7.85. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while La Jolla Pharmaceutical Company's is 2.3662. This would suggest that La Jolla Pharmaceutical Company's shares are significantly more volatile than the average for this exchange and represent a higher risk.
La Jolla Pharmaceutical Company overview
La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age and older. It offers GIAPREZA and XERAVA to hospitals and other healthcare organizations in the United States. Its product candidates that are in early stage clinical or preclinical development include TP-6076, an IV formulation of a fully synthetic fluorocycline derivative for the treatment of certain multidrug-resistant gram-negative bacteria; TP-271, an IV and oral formulation of a fully synthetic fluorocycline for the treatment of respiratory disease caused by bacterial biothreat and antibiotic-resistant public health pathogens, as well as bacterial pathogens associated with community-acquired bacterial pneumonia; and TP-2846, an IV formulation of a tetracycline for the treatment of acute myeloid leukemia. The company was incorporated in 1989 and is headquartered in San Diego, California. .
Stocks similar to La Jolla Pharmaceutical Company
La Jolla Pharmaceutical Company in the news
Our Take On La Jolla Pharmaceutical Company
Have Insiders Been Buying La Jolla Pharmaceutical Company (NASDAQ:LJPC) Shares?
Frequently asked questions
What percentage of La Jolla Pharmaceutical Company is owned by insiders or institutions?Currently 1.671% of La Jolla Pharmaceutical Company shares are held by insiders and 78.522% by institutions. How many people work for La Jolla Pharmaceutical Company?
Latest data suggests 59 work at La Jolla Pharmaceutical Company. When does the fiscal year end for La Jolla Pharmaceutical Company?
La Jolla Pharmaceutical Company's fiscal year ends in December. Where is La Jolla Pharmaceutical Company based?
La Jolla Pharmaceutical Company's address is: 4747 Executive Drive, San Diego, CA, United States, 92121 What is La Jolla Pharmaceutical Company's ISIN number?
La Jolla Pharmaceutical Company's international securities identification number is: US5034596040 What is La Jolla Pharmaceutical Company's CUSIP number?
La Jolla Pharmaceutical Company's Committee on Uniform Securities Identification Procedures number is: 503459505
More guides on Finder
-
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
-
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
-
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
-
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
-
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
-
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
-
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
-
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
-
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
-
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert